{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:32:48Z","timestamp":1759336368531,"version":"3.41.0"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:p>A newly deorphanized G protein-coupled receptor, GPR171, is found to be highly expressed within the periaqueductal gray, a pain-modulating region in the brain. Our recent research has shown that a GPR171 agonist increases morphine antinociception in male mice and opioid signaling <jats:italic toggle=\"yes\">in vitro<\/jats:italic>. The objective of this study was to evaluate the effects of combination treatment in females as well as whether chronic treatment can be used without exacerbating morphine-induced tolerance and withdrawal in female and male mice. Our results demonstrate that activation of GPR171 with an agonist attenuates morphine tolerance in both female and male mice on the tail-flick test, but not the hotplate test. Importantly, the GPR171 agonist in combination with morphine does not exacerbate morphine-induced tolerance and withdrawal during long-term morphine treatment. Taken together, these data suggest that the GPR171 agonist may be combined with morphine to maintain antinociception while reducing the dose of morphine and therefore reducing side effects and abuse liability. The outcome of this study is clearly an important step toward understanding the functional interactions between opioid receptors and GPR171 and developing safer therapeutics for long-term pain management.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000692","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T09:02:42Z","timestamp":1660035762000},"page":"442-451","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["GPR171 activation regulates morphine tolerance but not withdrawal in a test-dependent manner in mice"],"prefix":"10.1097","volume":"33","author":[{"given":"Leela","family":"Afrose","sequence":"first","affiliation":[{"name":"Department of Biology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max V.","family":"McDermott","sequence":"additional","affiliation":[{"name":"Department of Biology"},{"name":"Interdisciplinary Neuroscience Program, Utah State University, Logan, Utah"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashif I.","family":"Bhuiyan","sequence":"additional","affiliation":[{"name":"Chemistry and Biochemistry Department, Queens College of The City University of New York, Flushing, New York"},{"name":"Chemistry Doctoral Program"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjai K.","family":"Pathak","sequence":"additional","affiliation":[{"name":"Chemistry and Biochemistry Department, Queens College of The City University of New York, Flushing, New York"},{"name":"Chemistry Doctoral Program"},{"name":"Biochemistry Doctoral Program, The Graduate Center of The City University of New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin N.","family":"Bobeck","sequence":"additional","affiliation":[{"name":"Department of Biology"},{"name":"Interdisciplinary Neuroscience Program, Utah State University, Logan, Utah"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,8,5]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.bjp.0707277","article-title":"Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.","volume":"151","author":"Abul-Husn","year":"2007","journal-title":"Br J Pharmacol"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","article-title":"Molecular mechanisms of opioid receptor-dependent signaling and behavior.","volume":"115","author":"Al-Hasani","year":"2011","journal-title":"Anesthesiology"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0169-328X(03)00057-3","article-title":"Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal.","volume":"112","author":"Ammon","year":"2003","journal-title":"Brain Res Mol Brain Res"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41386-018-0127-4","article-title":"Neuronal and glial factors contributing to sex differences in opioid modulation of pain.","volume":"44","author":"Averitt","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pbb.2013.09.018","article-title":"Orexin receptor type-1 antagonist SB-334867 decreases morphine-induced antinociceptive effect in formalin test.","volume":"112","author":"Azhdari-Zarmehri","year":"2013","journal-title":"Pharmacol Biochem Behav"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0028-3908(84)90231-4","article-title":"Monosodium glutamate and analgesia induced by morphine. Test-specific effects.","volume":"23","author":"Badillo-Martinez","year":"1984","journal-title":"Neuropharmacology"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0301-0082(95)00009-K","article-title":"Functional characteristics of the midbrain periaqueductal gray.","volume":"46","author":"Behbehani","year":"1995","journal-title":"Prog Neurobiol"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1038\/npp.2014.62","article-title":"Contribution of adenylyl cyclase modulation of pre- and postsynaptic GABA neurotransmission to morphine antinociception and tolerance.","volume":"39","author":"Bobeck","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1038\/npp.2017.79","article-title":"The BigLEN-GPR171 peptide receptor system within the basolateral amygdala regulates anxiety-like behavior and contextual fear conditioning.","volume":"42","author":"Bobeck","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jpain.2012.05.005","article-title":"Differential development of antinociceptive tolerance to morphine and fentanyl is not linked to efficacy in the ventrolateral periaqueductal gray of the rat.","volume":"13","author":"Bobeck","year":"2012","journal-title":"J Pain"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pain.2009.09.008","article-title":"Drug dependent sex-differences in periaqueducatal gray mediated antinociception in the rat.","volume":"147","author":"Bobeck","year":"2009","journal-title":"Pain"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jpain.2019.03.002","article-title":"Lack of antinociceptive cross-tolerance with co-administration of morphine and fentanyl into the periaqueductal gray of male Sprague-Dawley rats.","volume":"20","author":"Bobeck","year":"2019","journal-title":"J Pain"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3959(85)90145-9","article-title":"Pain measurement: an overview.","volume":"22","author":"Chapman","year":"1985","journal-title":"Pain"},{"issue":"Suppl 1","key":"R14-20250614","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/11630060-000000000-00000","article-title":"The management of chronic pain in important patient subgroups.","volume":"32","author":"Cherubino","year":"2012","journal-title":"Clin Drug Investig"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3390\/biomedicines9030256","article-title":"GPR171 activation modulates nociceptor functions, alleviating pathologic pain.","volume":"9","author":"Cho","year":"2021","journal-title":"Biomedicines"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1124\/jpet.102.045575","article-title":"Antinociceptive synergy between \u03949-tetrahydrocannabinol and opioids after oral administration.","volume":"304","author":"Cichewicz","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050911","article-title":"Sex differences in development of morphine tolerance and dependence in the rat.","volume":"143","author":"Craft","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0304-3959(88)90042-5","article-title":"Synergy between the antinociceptive effects of intrathecal clonidine and systemic morphine in the rat.","volume":"32","author":"Drasner","year":"1988","journal-title":"Pain"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/npp.2016.131","article-title":"Toll-like receptor 4 mediates morphine-induced neuroinflammation and tolerance via soluble tumor necrosis factor signaling.","volume":"42","author":"Eidson","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"15952","DOI":"10.1523\/JNEUROSCI.1609-13.2013","article-title":"Blockade of toll-like receptor 4 attenuates morphine tolerance and facilitates the pain relieving properties of morphine.","volume":"33","author":"Eidson","year":"2013","journal-title":"J Neurosci"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.brainresbull.2016.09.009","article-title":"Modulation of nociception by medial pre-optic area orexin a receptors and its relation with morphine in male rats.","volume":"127","author":"Emam","year":"2016","journal-title":"Brain Res Bull"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0014-5793(89)80921-4","article-title":"Mu type opioid receptors in rat periaqueductal gray-enriched P2 membrane are coupled to G-protein-mediated inhibition of adenylyl cyclase.","volume":"253","author":"Fedynyshyn","year":"1989","journal-title":"FEBS Lett"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/bph.12663","article-title":"Heteromers of \u03bc-\u03b4 opioid receptors: new pharmacology and novel therapeutic possibilities.","volume":"172","author":"Fujita","year":"2015","journal-title":"Br J Pharmacol"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jpain.2012.03.009","article-title":"The economic costs of pain in the United States.","volume":"13","author":"Gaskin","year":"2012","journal-title":"J Pain"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"16211","DOI":"10.1073\/pnas.1312938110","article-title":"GPR171 is a hypothalamic G protein-coupled receptor for BigLEN, a neuropeptide involved in feeding.","volume":"110","author":"Gomes","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"ra43","DOI":"10.1126\/scisignal.aad0694","article-title":"Identification of GPR83 as the receptor for the neuroendocrine peptide PEN.","volume":"9","author":"Gomes","year":"2016","journal-title":"Sci Signal"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/npp.2010.197","article-title":"The role of TNF\u03b1 in the periaqueductal gray during naloxone-precipitated morphine withdrawal in rats.","volume":"36","author":"Hao","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.pbb.2003.12.020","article-title":"Morphine tolerance in male and female rats.","volume":"77","author":"Holtman","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/sj.npp.1301139","article-title":"Behavioral and electrophysiological evidence for opioid tolerance in adolescent rats.","volume":"32","author":"Ingram","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.tips.2019.04.001","article-title":"GPCRomics: an approach to discover GPCR drug targets.","volume":"40","author":"Insel","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"R31-20250614","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0306-4522(02)00458-X","article-title":"Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence.","volume":"115","author":"Kest","year":"2002","journal-title":"Neuroscience"},{"key":"R32-20250614","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.conb.2014.07.010","article-title":"Descending modulation of pain: the GABA disinhibition hypothesis of analgesia.","volume":"29","author":"Lau","year":"2014","journal-title":"Curr Opin Neurobiol"},{"key":"R33-20250614","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0031-6997(24)01514-X","article-title":"Animal models of nociception.","volume":"53","author":"Le Bars","year":"2001","journal-title":"Pharmacol Rev"},{"key":"R34-20250614","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/j.1460-9568.2008.06100.x","article-title":"Sexually dimorphic activation of the periaqueductal gray-rostral ventromedial medullary circuit during the development of tolerance to morphine in the rat.","volume":"27","author":"Loyd","year":"2008","journal-title":"Eur J Neurosci"},{"key":"R35-20250614","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3389\/fnins.2018.00886","article-title":"The contribution of the descending pain modulatory pathway in opioid tolerance.","volume":"12","author":"Lueptow","year":"2018","journal-title":"Front Neurosci"},{"key":"R36-20250614","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.neuropharm.2017.06.019","article-title":"Two delta opioid receptor subtypes are functional in single ventral tegmental area neurons, and can interact with the mu opioid receptor.","volume":"123","author":"Margolis","year":"2017","journal-title":"Neuropharmacology"},{"key":"R37-20250614","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1523\/JNEUROSCI.0062-05.2005","article-title":"Regulation of gene expression by chronic morphine and morphine withdrawal in the locus ceruleus and ventral tegmental area.","volume":"25","author":"McClung","year":"2005","journal-title":"J Neurosci"},{"key":"R38-20250614","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1124\/jpet.119.259242","article-title":"Opioid-induced signaling and antinociception are modulated by the recently deorphanized receptor, GPR171.","volume":"371","author":"McDermott","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"R39-20250614","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/dev.20392","article-title":"Regional Fos expression induced by morphine withdrawal in the 7-day-old rat.","volume":"51","author":"McPhie","year":"2009","journal-title":"Dev Psychobiol"},{"key":"R40-20250614","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.brainres.2009.07.100","article-title":"Glutamate modulation of antinociception, but not tolerance, produced by morphine microinjection into the periaqueductal gray of the rat.","volume":"1295","author":"Morgan","year":"2009","journal-title":"Brain Res"},{"key":"R41-20250614","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jpain.2005.12.009","article-title":"Morphine antinociceptive potency on chemical, mechanical, and thermal nociceptive tests in the rat.","volume":"7","author":"Morgan","year":"2006","journal-title":"J Pain"},{"key":"R42-20250614","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.pain.2008.09.009","article-title":"Periaqueductal gray neurons project to spinally projecting GABAergic neurons in the rostral ventromedial medulla.","volume":"140","author":"Morgan","year":"2008","journal-title":"Pain"},{"key":"R43-20250614","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00000542-199809000-00023","article-title":"Effects of intrathecal NMDA and non-NMDA antagonists on acute thermal nociception and their interaction with morphine.","volume":"89","author":"Nishiyama","year":"1998","journal-title":"Anesthesiology"},{"key":"R44-20250614","doi-asserted-by":"crossref","first-page":"940613","DOI":"10.1100\/2012\/940613","article-title":"An emerging new paradigm in opioid withdrawal: a critical role for glia-neuron signaling in the periaqueductal gray.","volume":"2012","author":"Ouyang","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"R45-20250614","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0022-3565(25)21481-1","article-title":"Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.","volume":"230","author":"Porreca","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"key":"R46-20250614","doi-asserted-by":"crossref","first-page":"695396","DOI":"10.3389\/fpain.2021.695396","article-title":"GPR171 agonist reduces chronic neuropathic and inflammatory pain in male, but not female mice.","volume":"2","author":"Ram","year":"2021","journal-title":"Front Pain Res (Lausanne)"},{"key":"R47-20250614","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejphar.2004.01.012","article-title":"Estrous cycle stage-dependent expression of acute tolerance to morphine analgesia in rats.","volume":"486","author":"Shekunova","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"R48-20250614","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0022-3565(24)29556-2","article-title":"Sex-related differences in antinociception and tolerance development following chronic intravenous infusion of morphine in the rat: modulatory role of testosterone via morphine clearance.","volume":"297","author":"South","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"R49-20250614","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0304-3940(96)12638-0","article-title":"Local administration of morphine decreases the extracellular level of GABA in the periaqueductal gray matter of freely moving rats.","volume":"209","author":"Stiller","year":"1996","journal-title":"Neurosci Lett"},{"key":"R50-20250614","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.drugalcdep.2011.10.025","article-title":"Functional relevance of \u03bc-\u03b4 opioid receptor heteromerization: a role in novel signaling and implications for the treatment of addiction disorders: from a symposium on new concepts in mu-opioid pharmacology.","volume":"121","author":"Stockton","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"R51-20250614","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1124\/mi.9.5.7","article-title":"In search of analgesia: emerging roles of GPCRs in pain.","volume":"9","author":"Stone","year":"2009","journal-title":"Mol Interv"},{"key":"R53-20250614","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0006-8993(91)91111-D","article-title":"A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function.","volume":"548","author":"Terwilliger","year":"1991","journal-title":"Brain Res"},{"key":"R54-20250614","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0022-3565(24)36562-0","article-title":"Characterization of neonatal rat fentanyl tolerance and dependence.","volume":"281","author":"Thornton","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"R55-20250614","doi-asserted-by":"crossref","first-page":"ra55","DOI":"10.1126\/scisignal.aac8035","article-title":"Identification of a small-molecule ligand that activates the neuropeptide receptor GPR171 and increases food intake.","volume":"9","author":"Wardman","year":"2016","journal-title":"Sci Signal"},{"key":"R56-20250614","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s12264-020-00515-5","article-title":"Mu-Opioid receptors expressed in glutamatergic neurons are essential for morphine withdrawal.","volume":"36","author":"Zhang","year":"2020","journal-title":"Neurosci Bull"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000692","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T22:02:23Z","timestamp":1749938543000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,5]]},"references-count":55,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000692","relation":{},"ISSN":["0955-8810"],"issn-type":[{"type":"print","value":"0955-8810"}],"subject":[],"published":{"date-parts":[[2022,8,5]]}}}